Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07217158

Role of ROS and cAMP-PKA Biomarkers in ADPKD

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

The primary objective is to determine the prognostic value of markers of ROS and cAMP-PKA signaling to assess disease severity and progression in patients with ADPKD.

Official title: Role of ROS and cAMP-PKA Signaling-related Biomarkers on Renal Disease Severity and Progression in ADPKD

Key Details

Gender

All

Age Range

15 Years - 70 Years

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2023-07-01

Completion Date

2027-06-30

Last Updated

2025-10-27

Healthy Volunteers

No

Locations (1)

Mayo Clinic

Rochester, Minnesota, United States